Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 25:12:113-126.
doi: 10.2147/PTT.S293107. eCollection 2022.

Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management

Eveline De Brandt  1 , Tom Hillary  1
Affiliations
Review

Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management

Eveline De Brandt et al. Psoriasis (Auckl). .

Abstract

Purpose: To review the literature on guidance on the follow-up of psoriasis and its comorbidities and to provide practical recommendations.

Patients and methods: A PubMed search was conducted using MeSH terms and free text keywords related to "psoriasis", "obesity", "hypertension", "diabetes", "dyslipidemia", "metabolic syndrome" and "Psoriatic arthritis". The search was conducted between September 2021 and January 2022. References of selected articles were scanned to identify additional articles.

Results: Recommendations on the follow-up of hypertension, obesity, dyslipidemia, type 2 diabetes, metabolic syndrome, psoriatic arthritis, non-alcoholic fatty liver disease and inflammatory bowel disease in psoriasis patients were extracted from the included articles. These data are presented in summary tables for both adults and children. A practical and feasible approach for each comorbidity is discussed.

Conclusion: Awareness among dermatologists for relevant psoriasis-associated comorbidities is crucial. The dermatologist should function as gatekeeper and screen for comorbidities, in order to make timely referrals when indicated.

Keywords: atherosclerosis; cardiovascular disease; comorbidities; liver disease; metabolic syndrome; psoriasis; psoriatic arthritis; screening.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

References

    1. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–385. doi: 10.1038/jid.2012.339 - DOI - PubMed
    1. Augustin M, Radtke MA, Glaeske G, et al. Epidemiology and comorbidity in children with psoriasis and atopic eczema. Dermatology. 2015;231(1):35–40. doi: 10.1159/000381913 - DOI - PubMed
    1. Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome. Endocr Rev. 2008;29(7):777–822. doi: 10.1210/er.2008-0024 - DOI - PMC - PubMed
    1. Singh S, Young P, Armstrong AW. Relationship between psoriasis and metabolic syndrome: a systematic review. G Ital Dermatol Venereol. 2016;151(6):663–677. - PubMed
    1. Chan WMM, Yew YW, Theng TSC, Liew CF, Oon HH. Prevalence of metabolic syndrome in patients with psoriasis: a cross-sectional study in Singapore. Singapore Med J. 2020;61(4):194–199. doi: 10.11622/smedj.2019152 - DOI - PMC - PubMed